Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Been looking at some solid dividend plays lately, and I think CL and ALB deserve attention if you're into that steady income strategy.
So here's the thing about dividend aristocrats - these companies have basically proven they can keep raising payouts year after year, which honestly says a lot about their business quality. Colgate-Palmolive caught my eye because they've been increasing dividends for 60 straight years. That's not a coincidence. Their oral care and pet nutrition lines have solid demand, and the brand strength lets them adjust pricing when inflation hits. Plus, hedge funds are clearly on board - they loaded up on over a million CL shares last quarter according to the data.
The analyst consensus backs this up too. CL is sitting at a Moderate Buy with five Buy ratings and five Holds. Price target is around $84.70, suggesting roughly 22% upside from current levels. TipRanks gives it a 9 out of 10 Smart Score, which is pretty strong.
Now ALB is interesting in a different way. They've got 29 consecutive years of dividend increases and they're positioned nicely in lithium. With EV demand still climbing, that lithium exposure matters. Hedge funds clearly see it the same way - 665,000 shares bought last quarter. The conviction from managers like Philippe Laffont shows real confidence here.
Analyst-wise, ALB looks even more bullish. 13 Buy ratings, three Holds, one Sell. Price target sits at $262.53, implying 71% upside potential. Perfect 10 Smart Score on TipRanks.
What I find interesting is that both these names are getting consistent buying pressure from serious money. During market volatility, companies that have actually proven they can maintain and grow dividends tend to hold up better. Not saying they're immune to downside, but the fundamentals plus the hedge fund positioning plus analyst sentiment all pointing the same direction is worth noting. If you're looking to add some defensive income exposure, both CL and ALB are worth deeper research.